HK1256412A1 - 基於變體的疾病診斷和追蹤 - Google Patents
基於變體的疾病診斷和追蹤Info
- Publication number
- HK1256412A1 HK1256412A1 HK18115544.9A HK18115544A HK1256412A1 HK 1256412 A1 HK1256412 A1 HK 1256412A1 HK 18115544 A HK18115544 A HK 18115544A HK 1256412 A1 HK1256412 A1 HK 1256412A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tracking
- based disease
- variant based
- disease diagnostics
- diagnostics
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Biomedical Technology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662286103P | 2016-01-22 | 2016-01-22 | |
PCT/US2017/014427 WO2017127742A1 (en) | 2016-01-22 | 2017-01-20 | Variant based disease diagnostics and tracking |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1256412A1 true HK1256412A1 (zh) | 2019-09-20 |
Family
ID=59360599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18115544.9A HK1256412A1 (zh) | 2016-01-22 | 2018-12-05 | 基於變體的疾病診斷和追蹤 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20170213008A1 (zh) |
EP (1) | EP3405574A4 (zh) |
JP (3) | JP2019509018A (zh) |
CN (1) | CN108603234A (zh) |
AU (2) | AU2017209330B2 (zh) |
CA (1) | CA3010418A1 (zh) |
HK (1) | HK1256412A1 (zh) |
WO (1) | WO2017127742A1 (zh) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3006792A1 (en) | 2015-12-08 | 2017-06-15 | Twinstrand Biosciences, Inc. | Improved adapters, methods, and compositions for duplex sequencing |
EP3552128A1 (en) | 2016-12-08 | 2019-10-16 | Life Technologies Corporation | Methods for detecting mutation load from a tumor sample |
US10699802B2 (en) | 2017-10-09 | 2020-06-30 | Strata Oncology, Inc. | Microsatellite instability characterization |
WO2019108807A1 (en) * | 2017-12-01 | 2019-06-06 | Personal Genome Diagnositics Inc. | Process for microsatellite instability detection |
CA3093092A1 (en) * | 2018-03-06 | 2019-09-12 | Cancer Research Technology Limited | Improvements in variant detection |
AU2019255613A1 (en) * | 2018-04-16 | 2020-11-12 | Memorial Sloan Kettering Cancer Center | Systems and methods for detecting cancer via cfDNA screening |
CN112639984A (zh) * | 2018-08-28 | 2021-04-09 | 生命科技股份有限公司 | 从肿瘤样品中检测突变负荷的方法 |
AU2019328344A1 (en) | 2018-08-31 | 2021-04-08 | Guardant Health, Inc. | Microsatellite instability detection in cell-free DNA |
US20210358569A1 (en) * | 2018-09-14 | 2021-11-18 | Lexent Bio, Inc. | Methods and systems for assessing microsatellite instability |
EP3881323A4 (en) * | 2018-11-13 | 2022-11-16 | Myriad Genetics, Inc. | METHODS AND SYSTEMS FOR SOMATIC MUTATIONS AND THEIR USES |
AU2019403273A1 (en) * | 2018-12-19 | 2021-08-05 | Grail, Llc | Cancer tissue source of origin prediction with multi-tier analysis of small variants in cell-free dna samples |
EP3809414A1 (en) * | 2019-10-15 | 2021-04-21 | Koninklijke Philips N.V. | Method and apparatus for assessing patient's response to therapy |
EP4066245A1 (en) * | 2019-11-27 | 2022-10-05 | Grail, LLC | Systems and methods for evaluating longitudinal biological feature data |
CN113684274B (zh) * | 2020-05-18 | 2022-06-03 | 普瑞基准生物医药(苏州)有限公司 | 用于恶性女性生殖细胞肿瘤诊断和治疗试剂盒 |
CN111785324B (zh) * | 2020-07-02 | 2021-02-02 | 深圳市海普洛斯生物科技有限公司 | 一种微卫星不稳定分析方法及装置 |
CN112086129B (zh) * | 2020-09-23 | 2021-04-06 | 深圳吉因加医学检验实验室 | 预测肿瘤组织cfDNA的方法及系统 |
CN113096728B (zh) * | 2021-06-10 | 2021-08-20 | 臻和(北京)生物科技有限公司 | 一种微小残余病灶的检测方法、装置、存储介质及设备 |
WO2023019110A1 (en) * | 2021-08-10 | 2023-02-16 | Foundation Medicine, Inc. | Methods and systems for detection of reversion mutations from genomic profiling data |
CN113990492B (zh) * | 2021-11-15 | 2022-08-26 | 至本医疗科技(上海)有限公司 | 确定关于实体瘤微小残留病灶的检测参数的方法、设备和存储介质 |
CN115679000B (zh) * | 2022-12-30 | 2023-03-21 | 臻和(北京)生物科技有限公司 | 微小残留病灶的检测方法、装置、设备和存储介质 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2513747C (en) * | 2003-01-24 | 2017-03-07 | University Of Utah | Methods of predicting mortality risk by determining telomere length |
EP1743031A4 (en) * | 2004-04-26 | 2008-05-28 | Childrens Medical Center | BLOOD PLATE BIOMARKERS FOR THE DETECTION OF ILLNESSES |
US20090298709A1 (en) * | 2008-05-28 | 2009-12-03 | Affymetrix, Inc. | Assays for determining telomere length and repeated sequence copy number |
US20110212855A1 (en) * | 2008-08-15 | 2011-09-01 | Decode Genetics Ehf. | Genetic Variants Predictive of Cancer Risk |
EP3483285B1 (en) * | 2011-02-09 | 2021-07-14 | Bio-Rad Laboratories, Inc. | Analysis of nucleic acids |
WO2012112804A1 (en) * | 2011-02-18 | 2012-08-23 | Raindance Technoligies, Inc. | Compositions and methods for molecular labeling |
WO2013086464A1 (en) * | 2011-12-07 | 2013-06-13 | The Broad Institute, Inc. | Markers associated with chronic lymphocytic leukemia prognosis and progression |
US20140129152A1 (en) * | 2012-08-29 | 2014-05-08 | Michael Beer | Methods, Systems and Devices Comprising Support Vector Machine for Regulatory Sequence Features |
US20150073724A1 (en) * | 2013-07-29 | 2015-03-12 | Agilent Technologies, Inc | Method for finding variants from targeted sequencing panels |
JP2015035212A (ja) * | 2013-07-29 | 2015-02-19 | アジレント・テクノロジーズ・インクAgilent Technologies, Inc. | ターゲットシークエンシングパネルから変異を見つける方法 |
EP3077545B1 (en) * | 2013-12-05 | 2020-09-16 | Centrillion Technology Holdings Corporation | Methods for sequencing nucleic acids |
US20160002717A1 (en) * | 2014-07-02 | 2016-01-07 | Boreal Genomics, Inc. | Determining mutation burden in circulating cell-free nucleic acid and associated risk of disease |
-
2017
- 2017-01-20 AU AU2017209330A patent/AU2017209330B2/en active Active
- 2017-01-20 US US15/411,879 patent/US20170213008A1/en not_active Abandoned
- 2017-01-20 JP JP2018534573A patent/JP2019509018A/ja active Pending
- 2017-01-20 CN CN201780007871.8A patent/CN108603234A/zh active Pending
- 2017-01-20 EP EP17742056.9A patent/EP3405574A4/en not_active Withdrawn
- 2017-01-20 CA CA3010418A patent/CA3010418A1/en active Pending
- 2017-01-20 WO PCT/US2017/014427 patent/WO2017127742A1/en active Application Filing
-
2018
- 2018-12-05 HK HK18115544.9A patent/HK1256412A1/zh unknown
-
2021
- 2021-11-05 JP JP2021180858A patent/JP2022031683A/ja active Pending
-
2023
- 2023-06-27 AU AU2023204105A patent/AU2023204105A1/en active Pending
- 2023-10-03 JP JP2023171938A patent/JP2024009859A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3405574A1 (en) | 2018-11-28 |
AU2017209330A1 (en) | 2018-07-19 |
CN108603234A (zh) | 2018-09-28 |
EP3405574A4 (en) | 2019-10-02 |
WO2017127742A1 (en) | 2017-07-27 |
AU2023204105A1 (en) | 2023-07-13 |
JP2019509018A (ja) | 2019-04-04 |
JP2024009859A (ja) | 2024-01-23 |
JP2022031683A (ja) | 2022-02-22 |
US20170213008A1 (en) | 2017-07-27 |
AU2017209330B2 (en) | 2023-05-04 |
CA3010418A1 (en) | 2017-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1256412A1 (zh) | 基於變體的疾病診斷和追蹤 | |
IL283321A (en) | Antibodies against muc16 and their uses | |
IL285375A (en) | Antibodies that bind to il-8 and their uses | |
HK1254861A1 (zh) | 抗lag3抗體及其用途 | |
IL260678B (en) | Systems and methods to improve diagnosis of diseases | |
HK1250238A1 (zh) | 抗angptl8抗體及其用途 | |
HK1256381A1 (zh) | 抗pacap抗體及其用途 | |
IL251837A0 (en) | Anti-endoglin antibodies and their uses | |
GB201503387D0 (en) | Anti-carbapenem antibodies and uses thereof | |
PL3292154T3 (pl) | Przeciwciała przeciwko ludzkiemu HER3 i ich zastosowania | |
PT3101132T (pt) | Anticorpo humano anti-transtirretina | |
PL3180356T3 (pl) | Ludzkie przeciwciało anty-fgfr4 | |
GB201609712D0 (en) | Disease targets and biomarkers | |
GB201712357D0 (en) | Spetral imaging | |
GB2550826B (en) | Tracking area configuration | |
EP3358825A4 (en) | IMAGING UNIT AND ENDOSCOPE | |
HK1254240A1 (zh) | 抗羥腐胺賴氨酸抗體及其用途 | |
IL254245A0 (en) | Imaging systems and methods | |
GB201504297D0 (en) | Diagnosis | |
GB201406616D0 (en) | Imaging | |
EP3535421C0 (en) | DIAGNOSTIC METHODS | |
GB2542888B (en) | Fingerprint imaging | |
GB2555564B (en) | Scatter imaging | |
GB201621964D0 (en) | Stroke diagnosis | |
GB201610207D0 (en) | Samsaroon Physiological Analytics |